Salomon & Ludwin »

Nektar Therapeutics shares owned by Salomon & Ludwin

Quarter-by-quarter ownership of Nektar Therapeutics (NKTR) shares owned by Salomon & Ludwin from 13F filings

Historical chart of Salomon & Ludwin investment in Nektar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nektar Therapeutics held by Salomon & Ludwin consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nektar Therapeutics by Salomon & Ludwin

Quarter filed Position value Share count Share price at filing
2024-12-31 $43 46 0.93
2024-09-30 $59 46 1.30
2024-06-30 $56 46 1.24
2024-03-31 $43 46 0.93
2023-12-31 $27 46 0.59
2023-09-30 $27 46 0.59

More positions owned by Salomon & Ludwin

Ishares S&p 500 Growth Etf (IVW)
Ishares Short Term Ntnl Etf (SUB)
Jpmorgan Ultra Shrt Etf (JMST)
Vanguard S&p 500 Etf Etf (VOO)
Technology Select Sector Etf (XLK)
Spdr Bloomberg 1 3 Mnth Etf (BIL)
Ishares S&p 500 Value Etf (IVE)
Spdr S&p 500 Etf Iv Etf (SPY)
Vanguard Muni Bnd Tax Etf (VTEB)
Ishares Core S&p Mid Cap Etf (IJH)
Ishares National Muni Etf (MUB)
Vanguard Ftse Developed Etf (VEA)
Microsoft Corporation (MSFT)
Vanguard Short Term Etf (VGSH)
Ishares Msci Eafe Etf Etf (EFA)

View all positions for Salomon & Ludwin

Top funds holding Nektar Therapeutics

BlackRock
Deep Track Capital
Vanguard Group
Samlyn Capital
Nantahala Capital Management
Acadian Asset Management
Eventide Asset Management
PRIMECAP Management Company
Woodline Partners
Millennium Management
TCG Crossover Management
Geode Capital Management
Renaissance Technologies
State Street Corporation
Jacobs Levy Equity Management

View all funds holding Nektar Therapeutics